West Pharmaceutical Servs (NYSE:WST) reported its Q3 earnings results on Thursday, October 27, 2022 at 06:00 AM.
Here’s what investors need to know about the announcement.
Earnings
West Pharmaceutical Servs missed estimated earnings by 4.25%, reporting an EPS of $2.03 versus an estimate of $2.12.
Revenue was down $19.60 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.26 which was followed by a 1.07% increase in the share price the next day.
Here’s a look at West Pharmaceutical Servs’s past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 2.21 | 2.12 | 1.91 | 1.80 |
| EPS Actual | 2.47 | 2.30 | 2.04 | 2.06 |
| Revenue Estimate | 755.57M | 720.92M | 710.20M | 687.09M |
| Revenue Actual | 771.30M | 720.00M | 730.80M | 706.50M |
To track all earnings releases for West Pharmaceutical Servs visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
